The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial

[1]  G. Moradi,et al.  COVID-19 and Parkinson’s disease: a systematic review and meta-analysis , 2022, Acta neurologica Belgica.

[2]  S. B. Singh,et al.  Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction , 2022, Behavioural Brain Research.

[3]  Seon-Cheol Park,et al.  The Relationship between Stress, Inflammation, and Depression , 2022, Biomedicines.

[4]  Mohammad Reza Rostami,et al.  Psychological outcomes of the COVID-19 pandemic in patients with Parkinson’s disease: A systematic review , 2022, Journal of Clinical Neuroscience.

[5]  Chunchen Xiang,et al.  Prevalence and clinical aspects of depression in Parkinson’s disease: A systematic review and meta‑analysis of 129 studies , 2022, Neuroscience & Biobehavioral Reviews.

[6]  S. Thobois,et al.  Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment , 2022, Drugs & Aging.

[7]  J. Pereira,et al.  Fatigue in Brazilian patients with Parkinson’s disease , 2022, Dementia & neuropsychologia.

[8]  Ka-Hing Wong,et al.  Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson's disease. , 2022, Food research international.

[9]  Shengyu Li,et al.  Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson's Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder. , 2022, Journal of agricultural and food chemistry.

[10]  J. Ruokolainen,et al.  Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection , 2021, Journal of advanced research.

[11]  F. Khorvash,et al.  The effects of synbiotic supplementation on oxidative stress and clinical symptoms in women with migraine: A double‐blind, placebo‐controlled, randomized trial , 2021, Journal of Functional Foods.

[12]  S. Patten,et al.  The effect of interventions targeting gut microbiota on depressive symptoms: a systematic review and meta-analysis , 2021, CMAJ open.

[13]  B. Mroczko,et al.  The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System , 2021, International journal of molecular sciences.

[14]  Cheryl C. H. Yang,et al.  Effects of Lactobacillus plantarum PS128 on Depressive Symptoms and Sleep Quality in Self-Reported Insomniacs: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial , 2021, Nutrients.

[15]  Chiung-Chu Chen,et al.  The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study , 2021, Frontiers in Nutrition.

[16]  Chieh-Hsi Wu,et al.  Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism , 2021, Frontiers in Aging Neuroscience.

[17]  Mehdi Moradinazar,et al.  The effects of co-administration of probiotics and prebiotics on chronic inflammation, and depression symptoms in patients with coronary artery diseases: a randomized clinical trial , 2021, Nutritional neuroscience.

[18]  R. Milev,et al.  The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study , 2021, Frontiers in Psychiatry.

[19]  Yanyan Jiang,et al.  Correlation between depression and quality of life in patients with Parkinson's disease , 2021, Clinical Neurology and Neurosurgery.

[20]  Neda Haghighat,et al.  The Effect of Synbiotic and Probiotic Supplementation on Mental Health Parameters in Patients Undergoing Hemodialysis: A Double-blind, Randomized, Placebo-controlled Trial , 2021, Indian journal of nephrology.

[21]  Yanbing Wang,et al.  The role of Short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. , 2021, Pharmacological research.

[22]  K. Chaudhuri,et al.  Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS , 2020, Movement disorders clinical practice.

[23]  F. Luo,et al.  Probiotics treatment improves cognitive impairment in patients and animals: A systematic review and meta-analysis , 2020, Neuroscience & Biobehavioral Reviews.

[24]  N. Ibrahim,et al.  Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson’s disease: A randomised controlled trial , 2020, PloS one.

[25]  L. Balbuena,et al.  Quality of life in Parkinson's disease: A systematic review and meta‐analysis of comparative studies , 2020, CNS neuroscience & therapeutics.

[26]  F. Shidfar,et al.  The effects of probiotic/synbiotic supplementation compared to placebo on biomarkers of oxidative stress in adults: a systematic review and meta-analysis of randomized controlled trials , 2020, Critical reviews in food science and nutrition.

[27]  V. Arolt,et al.  Anxiety disorders and post-traumatic stress disorder in patients with coronary heart disease , 2020 .

[28]  H. Hsieh-Li,et al.  Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease , 2020, Brain, Behavior, and Immunity.

[29]  A. Pisani,et al.  Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown , 2020, Movement disorders clinical practice.

[30]  F. Zhang,et al.  Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration , 2020, Oxidative medicine and cellular longevity.

[31]  Sang Ryong Kim,et al.  Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids , 2020, Antioxidants.

[32]  Jason K. Wang,et al.  Gut Microbiome Dysbiosis and Depression: a Comprehensive Review , 2020, Current Pain and Headache Reports.

[33]  M. Etemadifar,et al.  Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID‐19) Pandemic , 2020, Movement disorders : official journal of the Movement Disorder Society.

[34]  Chandragouda R. Patil,et al.  Role of oxidative stress in depression. , 2020, Drug discovery today.

[35]  Csaba Váradi.  Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms , 2020, Biology.

[36]  M. Mansournia,et al.  The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials. , 2020, Complementary therapies in medicine.

[37]  Brian B Koo,et al.  Implications of the Gut Microbiome in Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.

[38]  Patrik Brundin,et al.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. , 2020, Clinics in geriatric medicine.

[39]  M. Noroozian,et al.  Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson’s disease , 2019, Applied neuropsychology. Adult.

[40]  Neda Haghighat,et al.  Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial , 2019, Nutritional neuroscience.

[41]  V. Mok,et al.  Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial. , 2019, JAMA neurology.

[42]  M. Taghizadeh,et al.  Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. , 2019, Clinical nutrition.

[43]  R. Cantello,et al.  Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence , 2019, Front. Immunol..

[44]  Q. Jia,et al.  The effect of probiotic and synbiotic supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: A systematic review and meta‐analysis of randomized controlled trials , 2019, Pharmacological research.

[45]  N. Fallah,et al.  The Relation between Depression and Ischemic Heart Disease among Middle Aged People: a Case Control Study , 2019 .

[46]  A. Pisani,et al.  Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease , 2019, Journal of Neural Transmission.

[47]  Su-Hyun Lee,et al.  A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue , 2018, Korean journal of family medicine.

[48]  W. Rocca.  The burden of Parkinson's disease: a worldwide perspective , 2018, The Lancet Neurology.

[49]  R. McIntyre,et al.  Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? , 2018, Brain, Behavior, and Immunity.

[50]  A. Tessitore,et al.  Fatigue in Parkinson's disease: A systematic review and meta‐analysis , 2018, Movement disorders : official journal of the Movement Disorder Society.

[51]  J. Morgan,et al.  The dimensionality of fatigue in Parkinson’s disease , 2018, Journal of Translational Medicine.

[52]  Z. Khan,et al.  Oxidative stress-related biomarkers in Parkinson’s disease: A systematic review and meta-analysis , 2018, Iranian journal of neurology.

[53]  Yong Cheng,et al.  Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis , 2018, Front. Mol. Neurosci..

[54]  M. Ahmadpanah,et al.  The Effect of Synbiotic as an Adjuvant Therapy to Fluoxetine in Moderate Depression: A Randomized Multicenter Trial , 2018 .

[55]  Xiao-Liang Liu,et al.  Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review). , 2018, International journal of molecular medicine.

[56]  P. Singer,et al.  ESPEN guideline clinical nutrition in neurology. , 2017, Clinical nutrition.

[57]  Faris H. Lami,et al.  Prevalence and Assessment of Severity of Depression Among Ischemic Heart Disease Patients Attending Outpatient Cardiology Department Baghdad Teaching Hospital, Baghdad, Iraq , 2018 .

[58]  C. Campoy,et al.  Probiotic, Prebiotic, and Brain Development , 2017, Nutrients.

[59]  M. Tajabadi-Ebrahimi,et al.  The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial , 2017, Probiotics and Antimicrobial Proteins.

[60]  P. Clifton,et al.  Probiotics, prebiotics, synbiotics and insulin sensitivity , 2017, Nutrition Research Reviews.

[61]  D. Fouque,et al.  Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. , 2017, Future microbiology.

[62]  S. Illarioshkin,et al.  The state of systemic oxidative stress during Parkinson’s disease , 2017, Neurochemical Journal.

[63]  Manisha Bhatia,et al.  Gut microbiota’s effect on mental health: The gut-brain axis , 2017, Clinics and practice.

[64]  Weifen Li,et al.  Antioxidant Properties of Probiotic Bacteria , 2017, Nutrients.

[65]  Batol Zamani,et al.  Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial , 2017, British Journal of Nutrition.

[66]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[67]  Yulong Yin,et al.  Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? , 2016, Oxidative medicine and cellular longevity.

[68]  J. Pu,et al.  Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application , 2016, Parkinson's disease.

[69]  M. Kuijf,et al.  Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis , 2016, Movement disorders : official journal of the Movement Disorder Society.

[70]  R. Ataee,et al.  Polyphenolic Antioxidants and Neuronal Regeneration , 2016, Basic and clinical neuroscience.

[71]  J. Kiecolt-Glaser,et al.  Sex Differences in Depression: Does Inflammation Play a Role? , 2015, Current Psychiatry Reports.

[72]  G. Demaagd,et al.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. , 2015, P & T : a peer-reviewed journal for formulary management.

[73]  S. Koh,et al.  Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease , 2015, Journal of movement disorders.

[74]  V. Mishra,et al.  Probiotics as potential antioxidants: a systematic review. , 2015, Journal of agricultural and food chemistry.

[75]  N. Mohammadifard,et al.  Validation of a simplified food frequency questionnaire for the assessment of dietary habits in Iranian adults: Isfahan Healthy Heart Program, Iran , 2015, ARYA atherosclerosis.

[76]  E. Tolosa,et al.  The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) , 2015, Movement disorders : official journal of the Movement Disorder Society.

[77]  A. Verma,et al.  Oxidative stress and major depression. , 2014, Journal of clinical and diagnostic research : JCDR.

[78]  Y. Can,et al.  Evaluation of total antioxidant status, total oxidant status and oxidative stress index in patients with alopecia areata. , 2014, International journal of clinical and experimental medicine.

[79]  F. Farhadi,et al.  Reliability and Validity of the Persian Version of the Fatigue Severity Scale in Idiopathic Parkinson's Disease Patients , 2013, Parkinson's disease.

[80]  A. D'Souza,et al.  Cytokines and Toll-like receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation. , 2012, American journal of translational research.

[81]  P. Rabins,et al.  A comparison of nine scales to detect depression in Parkinson disease , 2012, Neurology.

[82]  J. Kong,et al.  Oxidative stress in neurodegenerative diseases , 2012, Neural regeneration research.

[83]  M. Jafarabadi,et al.  The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: Content and Construct Validity, Factor Structure, Internal Consistency and Stability , 2012 .

[84]  Derek Cridebring,et al.  Neurobiology of Depression and Anxiety in Parkinson's Disease , 2011, Parkinson's disease.

[85]  A. Lang.  A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials , 2011, Movement disorders : official journal of the Movement Disorder Society.

[86]  C. Jenkinson,et al.  Quality of life in patients with Parkinson’s disease: Translation and psychometric evaluation of the Iranian version of PDQ-39 , 2010, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[87]  Carmen Rodriguez-Blazquez,et al.  Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[88]  H. Kaviani,et al.  Reliability and validity of anxiety and depression hospital scales (HADS): Iranian patients with anxiety and depression disorders. , 2009 .

[89]  M. de Vrese,et al.  Probiotics, prebiotics, and synbiotics. , 2008, Advances in biochemical engineering/biotechnology.

[90]  Wei Jiang,et al.  Depression and ischemic heart disease: what have we learned from clinical trials? , 2007, Current opinion in cardiology.

[91]  A. Stiggelbout,et al.  Reliability and validity of the Beck depression inventory in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[92]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.